Dr. Azzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-6756
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2017
University of Balamand Faculty of MedicineClass of 2012
Certifications & Licensure
NY State Medical License 2017 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant Start of enrollment: 2023 Dec 11
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Adoptive cell therapy in acute myeloid leukemia: the current landscape and emerging strategies.Serena Tharakan, Douglas Tremblay, Jacques Azzi
Leukemia & Lymphoma. 2024-10-25 - 3 citationsOverall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.Sanjal H Desai, Michael A Spinner, Andrew M Evens, Alice Sykorova, Veronika Bachanova
Blood Advances. 2023-12-12 - 2 citationsCryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.Alla Keyzner, Jacques Azzi, Rita Jakubowski, Yelena Sinitsyn, Sharon Tindle
Transplantation Proceedings. 2023-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
